Gilead Presents Proof-of-Concept Data for GS-0976 in Nonalcoholic Steatohepatitis (NASH) at The International …

Press/Media: Press / Media

PeriodApr 21 2017

Media coverage

4

Media coverage

  • TitleGilead Presents Proof-of-Concept Data for GS-0976 in Nonalcoholic Steatohepatitis (NASH) at The International …
    Media name/outletYahoo! Finance
    CountryUnited States
    Date4/21/17
    PersonsEric J Lawitz
  • TitleGILEAD SCIENCES : Presents Proof-of-Concept Data for GS-0976 in Nonalcoholic Steatohepatitis (NASH) at The International Liver Congress™ 2017
    Media name/outlet4 Traders
    CountryUnited States
    Date4/21/17
    PersonsEric J Lawitz
  • TitleGilead Presents Proof-of-Concept Data for GS-0976 in Nonalcoholic Steatohepatitis (NASH) at The International Liver Congress ™ 2017
    Media name/outletStockwatch
    CountryCanada
    Date4/21/17
    PersonsEric J Lawitz
  • TitleGilead Sciences Inc: Gilead Presents Proof-of-Concept Data for GS-0976 in Nonalcoholic Steatohepatitis (NASH) at The International Liver Congress™ 2017 (Businesswire)
    Media name/outletAvanza Bank AB
    CountrySweden
    Date4/21/17
    PersonsEric J Lawitz